4.7 Article

Patients with rheumatoid arthritis presenting with monoor oligo-arthritis and high VAS-ratings remain the most fatigued during 5 years of follow-up

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Rheumatology

Fatigue in early rheumatoid arthritis: data from the Early Rheumatoid Arthritis Network

Onosi Sylvia Ifesemen et al.

Summary: The study aims to describe the prevalence, risk factors, and longitudinal course of fatigue in early rheumatoid arthritis (RA) patients. The findings suggest that fatigue is common and persistent in early RA, and diverse characteristics indicative of central mechanisms are associated with persistent fatigue.

RHEUMATOLOGY (2022)

Article Rheumatology

Fatigue in patients with early rheumatoid arthritis undergoing treat-to-target therapy: predictors and response to treatment

Karen Holten et al.

Summary: Fatigue is a common symptom in early RA patients, with a rapid and sustained reduction during treatment. Low objective disease activity and high patient global assessment at baseline were predictors of clinically relevant fatigue at 24 months.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

Cluster analysis identifies unmet healthcare needs among patients with rheumatoid arthritis

N. Mars et al.

Summary: The study found that the majority of RA patients had favorable outcomes and low costs, while a large group of patients were characterized by chronic pain, disability, and fatigue not directly linked to disease activity. The highest healthcare costs were associated with high disease activity or comorbidities.

SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2022)

Article Rheumatology

Longitudinal trajectories of fatigue in early RA: the role of inflammation, perceived disease impact and early treatment response

Michael Doumen et al.

Summary: Objective fatigue is common in early rheumatoid arthritis (RA), with its levels and trajectories associated with disease activity and clinical outcomes. Early inflammatory disease control strongly improved long-term fatigue, but most patients do not achieve sustained fatigue improvement despite intensive therapy.

ANNALS OF THE RHEUMATIC DISEASES (2022)

Article Rheumatology

Remotely delivered cognitive behavioural and personalised exercise interventions for fatigue severity and impact in inflammatory rheumatic diseases (LIFT): a multicentre, randomised, controlled, open-label, parallel-group trial

Eva-Maria Bachmair et al.

Summary: Background: Chronic fatigue is a poorly managed problem in people with inflammatory rheumatic diseases. Cognitive behavioural approaches (CBA) and personalised exercise programmes (PEP) can be effective, but they are not often implemented because their effectivenesses across the different inflammatory rheumatic diseases are unknown and regular face-to-face sessions are often undesirable, especially during a pandemic. We hypothesised that remotely delivered CBA and PEP would effectively alleviate fatigue severity and life impact across inflammatory rheumatic diseases. Methods: LIFT is a multicentre, randomised, controlled, open-label, parallel-group trial to assess usual care alongside telephone-delivered CBA or PEP against usual care alone in UK hospitals. Patients with any stable inflammatory rheumatic disease were eligible if they reported clinically significant, persistent fatigue. Treatment allocation was assigned by a web-based randomisation system. CBA and PEP sessions were delivered over 6 months by trained health professionals in rheumatology. Coprimary outcomes were fatigue severity (Chalder Fatigue Scale) and impact (Fatigue Severity Scale) at 56 weeks. The primary analysis was by full analysis set. This study was registered at ClinicalTrials.gov (NCT03248518). Findings: From Sept 4,2017, to Sept 30,2019, we randomly assigned and treated 367 participants to PEP (n=124; one participant withdrew after being randomly assinged), CBA (n=121), or usual care alone (n=122), of whom 274 (75%) were women and 92 (25%) were men with an overall mean age of 57.5 (SD 12.7) years. Analyses for Chalder Fatigue Scale induded 101 participants in the PEP group, 107 in the CBA group, and 107 in the usual care group and for Fatigue Severity Scale included 101 in PEP, 106 in CBA, and 107 in usual care groups. PEP and CBA significantly improved fatigue severity (Chalder Fatigue Scale; PEP: adjusted mean difference -3.03 [97.5% CI -5.05 to -1.02], p=0.0007; CBA: -2.36 [-4.28 to -0.44], p=0.0058) and fatigue impact (Fatigue Severity Scale; PEP: -0.64 [-0.95 to -0.33], p<0.0001; CBA: -0.58 [-0.87 to -0.28], 0.0001); compared with usual care alone at 56 weeks. No trial-related serious adverse events were reported. Interpretation: Telephone-delivered CBA and PEP produced and maintained statistically and clinically significant reductions in the severity and impact of fatigue in a variety of inflammatory rheumatic diseases. These interventions should be considered as a key component of inflammatory rheumatic disease management in routine clinical practice. Copyright (C) 2022 The Author(s). Published by Elsevier Ltd.

LANCET RHEUMATOLOGY (2022)

Review Rheumatology

Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis

Kaleb Michaud et al.

Summary: This study evaluated the nature and burden of residual disease in RA patients who met treatment targets, finding that some patients still had residual symptoms despite achieving LDA or remission. Needs for improvement in pain, fatigue, and function were highlighted, emphasizing the importance of standardized reporting in future studies.

ARTHRITIS CARE & RESEARCH (2021)

Article Rheumatology

Improvements in Fatigue Lag Behind Disease Remission in Early Rheumatoid Arthritis: Results From the Canadian Early Arthritis Cohort

Melissa Holdren et al.

Summary: Fatigue is common in early RA, and improvements may occur after remission. Early treatment response within 3 months after treatment initiation was associated with short-term and long-term improvements in fatigue over time.

ARTHRITIS & RHEUMATOLOGY (2021)

Article Rheumatology

The impact of different (rheumatoid) arthritis phenotypes on patients' lives

Nathalie Luurssen-Masurel et al.

Summary: This study compared patient-reported outcomes between three different arthritis phenotypes at diagnosis, after two years, and over time. The results showed that autoantibody-negative RA patients had the highest disease burden, with greater functional impairment and poorer physical health compared to the other phenotypes. Despite improvements after two years of treatment, all phenotypes still had a significant impact on patients' lives, particularly in physical aspects.

RHEUMATOLOGY (2021)

Review Rheumatology

Management of Fatigue in Rheumatoid Arthritis

Janet E. Pope

RMD OPEN (2020)

Review Immunology

Fatigue, Sleep, and Autoimmune and Related Disorders

Mark R. Zielinski et al.

FRONTIERS IN IMMUNOLOGY (2019)

Review Medicine, General & Internal

Diagnosis and Management of Rheumatoid Arthritis A Review

Daniel Aletaha et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)

Article Clinical Neurology

Characterizing classes of fibromyalgia within the continuum of central sensitization syndrome

Fred Davis et al.

JOURNAL OF PAIN RESEARCH (2018)

Article Rheumatology

Fatigue in rheumatoid arthritis; a persistent problem: a large longitudinal study

Hanna W. van Steenbergen et al.

RMD OPEN (2015)

Review Rheumatology

Fatigue and Factors Related to Fatigue in Rheumatoid Arthritis: A Systematic Review

Stephanie Nikolaus et al.

ARTHRITIS CARE & RESEARCH (2013)

Article Rheumatology

Fatigue in rheumatoid arthritis reflects pain, not disease activity

L. C. Pollard et al.

RHEUMATOLOGY (2006)

Article Rheumatology

Outcomes generated by patients with rheumatoid arthritis: How important are they?

Sarah Hewlett et al.

MUSCULOSKELETAL CARE (2005)